Bots, editor, reviewer, Administrators
13,951
edits
No edit summary |
No edit summary |
||
Line 1,946: | Line 1,946: | ||
"title" : "Telmisartan, ramipril, or both in patients at high risk for vascular events", | "title" : "Telmisartan, ramipril, or both in patients at high risk for vascular events", | ||
"pmid" : "18378520" | "pmid" : "18378520" | ||
}, | |||
{ | |||
"timestamp" : "2014-06-20T00:26:08Z", | |||
"briefDesignDescription" : "ASA/warfarin vs. warfarin in AF", | |||
"fulltexturl" : "http://circ.ahajournals.org/content/128/7/721.long", | |||
"pageid" : 1769, | |||
"pdfurl" : "http://circ.ahajournals.org/content/128/7/721.full.pdf", | |||
"trainingLevel" : "Fellow", | |||
"citation" : "Steinberg BA, <i>et al</i>. \"Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry\". <i>Circulation</i>. 2013. 128(7):721-8.", | |||
"subspecialties" : "Cardiology;Neurology", | |||
"expansion" : "Outcomes Registry for Better Informed Treatment of Atrial Fibrillation", | |||
"briefResultsDescription" : "ASA/warfarin associated with more bleeding, fewer CV events", | |||
"published" : "2013-08-13", | |||
"pageName" : "ORBIT-AF", | |||
"diseases" : "Atrial Fibrillation;Stroke", | |||
"abbreviation" : "ORBIT-AF", | |||
"title" : "Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry", | |||
"pmid" : "23861512" | |||
}, | }, | ||
{ | { |